What is Megan Pawlowski's NPI number?

Megan Pawlowski's National Provider Identifier (NPI) is 1033592142, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Megan Pawlowski's specialty?

Megan Pawlowski is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).

Where is Megan Pawlowski located?

Megan Pawlowski's practice location on file with NPPES is 3548 Route 9, Old Bridge, NJ 08857-2765.

What is Megan Pawlowski's phone number?

The practice phone number listed in the NPPES registry for Megan Pawlowski is (732) 679-6300.

Does Megan Pawlowski accept Medicare?

Megan Pawlowski is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Megan Pawlowski's NPI active?

Yes — Megan Pawlowski's NPI (1033592142) is active in the NPPES registry as of the last update on 2017-10-23.

IndividualActiveAccepts Medicare

Megan Pawlowski, PA-C

NPI 1033592142 · Physician Assistant · Old Bridge, NJ

Megan Pawlowski, PA-C is a Physician Assistant provider in Old Bridge, NJ (NPI 1033592142).

Provider details

NPI number: 1033592142
Entity type: Individual
Primary specialty: Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
Credential: PA-C
Sex: Female
Sole proprietor: No
License: 25MP00370400 (NJ)

Practice location

3548 Route 9

Suite 2

Old Bridge, NJ 08857-2765

Phone: (732) 679-6300

Fax: (732) 679-9566

Street-level locationGet directions

More NJ providers

Mailing address

3548 Route 9 Ste 2

Old Bridge, NJ 08857-2765

Specialties & taxonomies

Physician AssistantPrimary363A00000XLicense 25MP00370400 (NJ)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(83/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
11 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
2,598 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	535	$84
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	406	$118
Biopsy of Related Skin Growth, First Growth11102	324	$92
Biopsy of Related Skin Growth, Each Additional Growth11103	309	$47
Destruction of Precancer Skin Growth, 2-14 Growths17003	308	$6
Destruction of Precancer Skin Growth, 15 Or More Growths17004

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	141	116
Clobetasol Propionate	96	67
Ketoconazole	68	37
Desonide	44	32
Ammonium Lactate	43	33
Mupirocin	41	34
Metronidazole	39	24
Ciclopirox	17	12

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,268 across 150 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2015-07-07
Last updated: 2017-10-23

Frequently asked questions

What is Megan Pawlowski's NPI number?: Megan Pawlowski's National Provider Identifier (NPI) is 1033592142, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Megan Pawlowski's specialty?: Megan Pawlowski is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
Where is Megan Pawlowski located?: Megan Pawlowski's practice location on file with NPPES is 3548 Route 9, Old Bridge, NJ 08857-2765.
What is Megan Pawlowski's phone number?: The practice phone number listed in the NPPES registry for Megan Pawlowski is (732) 679-6300.
Does Megan Pawlowski accept Medicare?: Megan Pawlowski is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Megan Pawlowski's NPI active?: Yes — Megan Pawlowski's NPI (1033592142) is active in the NPPES registry as of the last update on 2017-10-23.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	535	$84
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	406	$118
Biopsy of Related Skin Growth, First Growth11102	324	$92
Biopsy of Related Skin Growth, Each Additional Growth11103	309	$47
Destruction of Precancer Skin Growth, 2-14 Growths17003	308	$6
Destruction of Precancer Skin Growth, 15 Or More Growths17004

Drug

Part D claims (2024)

Beneficiaries

Triamcinolone Acetonide

141

116

Clobetasol Propionate

Ketoconazole

Desonide

Ammonium Lactate

Mupirocin

Metronidazole

Ciclopirox

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,268 across 150 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments